Genomics BioSci & Tech
Taipei, Taiwan· Est.
Taiwan’s leading full‑service genomics and CDMO provider delivering sequencing, synthesis, and clinical testing solutions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwan’s leading full‑service genomics and CDMO provider delivering sequencing, synthesis, and clinical testing solutions.
OncologyGenetic DisordersReproductive Health
Technology Platform
Integrated multi‑generation NGS platforms combined with proprietary bioinformatics pipelines and GMP‑compliant nucleic‑acid/peptide synthesis for research, diagnostics, and CDMO services.
Opportunities
Expanding clinical NGS testing reimbursement in Taiwan and scaling CDMO services for Asia‑Pacific gene‑therapy developers.
Risk Factors
Intense competition from global sequencing service providers and regulatory changes affecting LDT approvals.
Competitive Landscape
Competes with Illumina, BGI, and Novogene on sequencing services, differentiating through local expertise, integrated CDMO capabilities, and strong government partnerships.